electroCore, Inc. (NASDAQ:ECOR) Q3 2023 Earnings Call Transcript

Dan Goldberger: So, absolutely. We start off in neurology, where the headache specialists live. We spend a lot of time in pain management. We spend a lot of time in behavioral health, where we talk about headache in depression, headache in PTSD, headache in substance abuse. Women’s health is a call point. More and more of the VA hospitals have a general wellness department, frankly. And then ultimately, we get into primary care as well, where they see headache, where they see stress and anxiety and on and on. So as word gets out, we just have more and more call points within each facility.

Walter Schenker: Okay. Thank you, Dan.

Dan Goldberger: Thank you, Walter.

Operator: And it looks like we have reached the end of the question-and-answer session. I’ll now turn the call back over to CEO, Dan Goldberger for closing remarks.

Dan Goldberger: Thank you, operator, and thank you, everybody, for joining our call. I want to give special thanks to all of our employees who work tirelessly to deliver this amazing therapy to patients. Team’s done a great job of staying nimble, scaling the business, and responding to the needs of our customers and healthcare providers alike. I also want to thank healthcare professionals and their patients for their loyal support of gammaCore therapy. We’re thankful for the support of AFRL, NIDA, the National Institute on Drug Abuse, the NFL Players Association for supporting our new product initiatives and working on those grants for investigator initiated trials. And of course Veterans Day is coming up. And so we greatly appreciate your service for those of you who are participating in Veterans Day activities.

Operator: Thank you all. And we look forward to speaking with you again in a few months.